University of Colorado Anschutz

10/02/2026

researchers are testing whether drones can deliver freeze-dried plasma directly to critically injured patients when conventional transportation cannot get them to a hospital fast enough—a concept that represents a potential shift in emergency medicine. 🏥 This new approach could not only transform medical care in warzones, but also be applicable to disasters and remote communities.

“We’ve spent years learning how to keep wounded service members alive when the hospital is far away, and almost everything we’ve learned has ended up helping civilians. This is the same pattern. If a drone can put plasma in a medic’s hands hundreds of miles from a blood bank, it can do the same for a paramedic on a mountain road,” said Vik Bebarta, MD, who chairs the CU Anschutz Department of Emergency Medicine and founded the CU Anschutz Combat Medicine Research Center.

🔗 Learn more about the study: https://bit.ly/3U6f9F0

09/29/2026

We push ourselves to see how far we can go. At , we push further because what lies beyond the limits of today could change someone’s tomorrow.

10.04.2026

09/28/2026

We are thrilled to announce a $4 million investment in the Trifinio Center for Human Development in rural, southwest Guatemala. Established more than a decade ago through a partnership among the Colorado School of Public Health, Children’s Hospital Colorado, AgroAmérica and community partners in Guatemala, the Trifinio Center was created to support the health and well-being of banana workers, their families and neighboring communities.

What started as a bold idea has grown into a campuswide commitment to global health where students, faculty and clinicians provide clinical care, maternal and child health, reproductive health and youth leadership programs to those who otherwise may not have access.

This funding is made possible through the visionary leadership of the Fernando Bolaños Family Foundation and joint funding partnership from the Colorado School of Public Health, School of Medicine, College of Nursing, Skaggs School of Pharmacy and Pharmaceutical Sciences, and School of Dental Medicine.

Learn more about the Trifinio Center: https://bit.ly/4xN0E6Y.

09/26/2026

Perimenopause, which affects more than 4 billion people, can bring brain fog, hot flashes, declining bone density and mood changes. As awareness grows, new research is prompting providers to reconsider the role of hormone therapy in managing symptoms.

reproductive endocrinologist Nanette Santoro, MD, recently joined Science Friday to discuss her research on perimenopause and what it’s revealing about the effects of hormone therapy.

After decades of controversy over prescribing hormone therapy for perimenopause, many providers are reconsidering their approach.

09/25/2026

September is Su***de Prevention Month. 💛 About half of youth who pass by su***de have no prior mental health histories or contacts with the mental health system, making early identification especially challenging.

Researchers at and Children’s Hospital Colorado analyzed more than 10,000 youth su***des over a decade to develop a first-of-its-kind classification system that groups cases by shared characteristics.

1️⃣ Crisis: Youth in this classification faced an apparent interpersonal or school-related crisis. They generally did not have indications of prior mental health concerns.
2️⃣ Disclosing: These children told somebody that they had suicidal thoughts or intentions that could be detected.
3️⃣ Identified: Heavily female, this group tended to be in mental health treatment, experiencing regular stressors.
4️⃣ Surveillance: The researchers could not clearly assign youth in this classification to one of the other groups because there was not enough available data, highlighting the reporting gaps that need to be overcome.
5️⃣ Hidden: These individuals were not disclosing, had minimal interactions with the healthcare system, were not clearly in crisis and did not have elevated rates of substances in their toxicology reports.

Researchers hope this newly created classification system highlighting warning signs and gaps in screening can help make a difference in youth su***de treatment and prevention.

You can read the full article here: https://bit.ly/4xPu5oJ.

09/24/2026

For some people, shingles pain doesn't end when the infection does. It can linger for months—or even years, with no clear scientific explanation as to why.

Now, new research from suggests that tiny particles in the blood, called exosomes, may continue sending inflammatory signals to nerve cells long after the virus is gone. The discovery could help pave the way for new treatments that target the underlying cause of lingering shingles pain.

🔗 Learn More: https://bit.ly/4rwGRXN.

09/23/2026

Thank you to everyone who joined us last week for the 12th annual Block Party! This year, we saw a record number of booths from campus and community organizations. This is one of our favorite campus traditions! 🖤 💛

09/22/2026

The CU Anschutz Cancer Center is proud to announce Wells Messersmith, MD, as the next director!

“In the next hour, one Coloradan will die of cancer on average—more than 8,700 deaths a year in our state,” says Messersmith. “I’ve been working here for 19 years. These patients are my neighbors, my colleagues, and my family. We need to ensure we have strong science and clinical trial opportunities here so patients have access to them. I want to ensure that Colorado patients don’t have to get into an airplane to get access to the most promising treatments.”

Read about Messersmith's vision for the cancer center and why campus leadership welcomes his appointment: https://news.cuanschutz.edu/cancer-center/messersmith-cancer-center-director

09/22/2026

has received an anonymous $50 million gift to transform care for patients with cerebrospinal fluid (CSF) leaks, one of the most underdiagnosed and undertreated neurological conditions in medicine.

Inspired by the life-changing work of Andrew Callen, MD, his neurosurgical partner Peter Lennarson, MD, and the CSF Leak Program team, the landmark gift, one of the largest in campus history, will expand the already nationally recognized program by broadening access to specialized care, advancing research and diagnostic expertise and further solidifying CU Anschutz as one of the nation's leading destinations for CSF leak diagnosis and treatment.

👉 Read more about how this extraordinary gift will transform CSF care: https://bit.ly/4yOMLGf

09/18/2026

Physicians at are the first in the Rocky Mountain region to perform a dual-target focused ultrasound procedure for people with advanced Parkinson’s disease.

Performed by a team led by neurosurgeon Daniel Kramer, MD, and neurologist Drew Kern, MD, MS, the procedure uses focused ultrasound to target two areas of the brain involved in Parkinson’s during the same outpatient procedure.

🧠 Learn more about the procedure here: https://bit.ly/4dnJqpe.